Picture of Odi Pharma AB (publ) logo

ODI Odi Pharma AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Odi Pharma Says Co Does Not See Any Impact On Mid- And Long-Term Goals Following Covid-19

April 7 (Reuters) - Odi Pharma AB (publ)  ODI.TE :
    * STATUS UPDATE IN CONNECTION TO COVID-19
    * BOARD OF DIRECTORS DOES NOT SEE ANY IMPACT ON COMPANY'S
MID- AND
LONG-TERM GOALS DUE TO COVID-19
    * ODI PHARMA- ODI DOES NOT SEE ANY IMPACT ON MID- AND
LONG-TERM
GOALS FOLLOWING COVID-19
    * BOARD OF DIRECTORS AND MANAGEMENT CURRENTLY FORECAST A
DELAY OF
FIRST SALES OF PRODUCT BY APPROXIMATELY THREE MONTHS.
    * FORECAST A DELAY OF FIRST SALES OF PRODUCT BY
APPROXIMATELY
THREE MONTHS

Source text for Eikon:  ID:nWkr2F0gDT 
Further company coverage:  ODI.TE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Odi Pharma AB (publ)

See all news